Canada’s health technology assessment (HTA) body is seeking to expedite patient access to new medicines by expanding its pilot mechanism for rolling reimbursement reviews of COVID-19 drugs to include all other types of products.
The rolling reimbursement review process was launched for use with COVID-19 products last September, but since then “the pharmaceutical industry...







